Core Viewpoint - Neuralink, founded by Elon Musk, has successfully raised $600 million in funding, achieving a pre-money valuation of $9 billion, marking its status as a "super unicorn" after nine years of development [4][10][14]. Funding and Growth - Since its inception in 2016, Neuralink has raised over $1.2 billion in total funding, with significant contributions from various investors including Founders Fund, DFJ Growth, Google Ventures, and Vy Capital [10][12][14]. - The company completed its Series D funding round, raising $280 million led by Founders Fund, followed by an additional $43 million in a D round extension [13]. - Following the approval for human clinical trials, Neuralink's valuation surged to approximately $7 billion, with recent reports indicating a pre-money valuation of $9 billion after the latest funding round [12][13]. Technological Advancements - Neuralink has developed an implantable brain-machine interface (BCI) device capable of inserting 1,024 electrode wires into the brain to collect signals, which are then transmitted wirelessly to external devices [8]. - The company has successfully conducted three human trials, allowing patients to control computers and play video games using their thoughts, demonstrating the potential of the technology for medical applications [9][18]. Industry Landscape - The brain-machine interface sector is rapidly evolving, with numerous companies in China, such as Qiangnao Technology and Zhiruan Medical, also making significant strides in this field [16]. - Major investment firms, including Sequoia Capital and Hillhouse Capital, have entered the brain-machine interface market, indicating a growing interest and potential for innovation [16]. - The global market for brain-machine interfaces in the medical field is projected to grow from $40 billion in 2030 to $145 billion by 2040, highlighting the industry's expansive future [20].
估值600多亿,马斯克的超级独角兽又融资了
36氪·2025-06-06 00:26